A Meta Analysis on Cardiac Vascular Disease with Obesity

Thirty percent of all deaths that occur each year can be attributed to heart disease, stroke, and other forms of cardiovascular disease. The World Health Organisation (WHO) predicts that by the year 2030, the annual death toll from cardiovascular diseases will have increased to 22.2 million, up from the present annual total of 17.9 million. Mortality rates tend to go up in populations as they get older. The chance of dying from cardiovascular disease is significantly higher for females (51%) than it is for males (42%). The majority of people treat and prevent cardiovascular disease by using plant-based medications (also known as phytochemicals), either in addition to or in instead of pharmaceuticals that are readily available on the market. In this study, the efficacy of treating cardiovascular illness is evaluated using 92 different plants, including 15 terrestrial plants. A number of different medicinal herbs, including Daucus carota, Nerium oleander, Amaranthus Viridis, Ginkgo biloba, Terminalia arjuna, Picrorhiza kurroa, Salvia miltiorrhiza, Tinospora cordifolia, Mucuna pruriens, Hydrocotyle asiatica, Bombax ceiba, and Andrographis paniculate, are utilised to treat cardiovascular disease. There are a variety of active phytochemicals found in these plants, some of which include flavonoids, polyphenols, plant sterols, plant sulphur compounds, and terpenoids. Flavonoids, in general, are known to increase vasodilation by inhibiting the oxidation of low-density lipoprotein (LDL). Plant sterols reduce the amount of cholesterol in the blood, which in turn protects against cardiovascular disease. Plant sulphur compounds protect against cardiovascular disease in addition to their role in the activation of nuclear factor-erythroid factor 2-related factor 2 (Nrf2) and the inhibition of cholesterol formation. The incidence of cardiovascular disease can be reduced by increasing the synthesis of ATP in mitochondria, and terpenoids can diminish atherosclerotic lesion in the aortic valve. Even though several physiologically active compounds with acknowledged biological functions have been found in a wide variety of plants, the prevalence of cardiovascular disease continues to rise, making it imperative that effective CVD prevention and treatment strategies be developed. More research is required to understand both the mechanism and the individual phytochemicals in plants that treat CVD. GRAPHICAL ABSTRACT

mentioning

confidence: 99%

Plant & its Bioactive Components Uses in Cardio-Potential Diseases: A Sectional Study for Different Herbs

Kumar,

Sood,

Nirala

et al. 2023

Diabetic Retinopathy: Current Understanding, Mechanisms and Treatment Strategies

Amjad,

Gupta,

Anamika

et al. 2024

Researchers have been assuming about the possible connection between the eye and the central nervous system (CNS) for a considerable amount of time. This is primarily due to the fact that the eye is considered to be an extension of the brain, which is a reasonable assumption. The neural tube is the beginning of both structures, and neurons are the building blocks of both structures. Retinal ganglionic cells, also known as RGCs, are a specific type of cell that are found in the retina. These cells are responsible for receiving light signals from the environment around them and then transmitting them to photoreceptors, which are involved in the process of vision. The retina, which is found inside the eye, is responsible for converting light into electrical impulses, which are then sent to the brain through the optic nerve. Glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy are only few of the eye illnesses that can be caused by chronic progressive neurodegeneration of the retina, which is more prevalent in older people. It is the elderly who are most likely to be affected by these eye disorders; nevertheless, younger people are also susceptible to them and may experience permanent vision loss or a reduction in their eyesight. In most cases, neurodegenerative disorders that are characteristic of CSN are characterised by common symptoms and a cause that is only partially understood. Although certain risk factors have been identified, they do not account for all instances. On the other hand, according to a number of studies, several illnesses of the central nervous system (CNS), such as Alzheimer's disease (AD) and Parkinson's disease (PD), which are responsible for a significant amount of mortality and morbidity on a global scale, display distinctive alterations at the ocular level. It is helpful to be aware of potential linkages in order to have a better understanding of the mechanics on which onset occurs. In addition, experts have not yet reached a consensus regarding the factors that are responsible for these various disorders. In this overview, the symptoms of ocular illnesses are discussed in detail, with a particular focus on the interaction between the brain and the eye. At some point in the future, a more in-depth understanding could be of assistance in the development of innovative treatments that could help reduce or prevent blindness and improve quality of life.

Therapeutic Approaches of Nutraceuticals in Neurological Disorders: A Review

Kumar,

Gupta,

Anamika

et al. 2024

A big problem in healthcare around the world is neurological illnesses. There is a huge healthcare and financial burden on society worldwide due to the dramatically increased risk of chronic sickness and diseases linked with posed lifestyle changes. Fine treatment for sick illnesses with few known adverse effects is the goal of research. A number of functional food studies have been launched in the last few decades in an effort to identify meals with enhanced therapeutic activity and reduced adverse effects. As a result, research into nutraceutical therapy for illness prevention and various extraction procedures for disorders has been underway. Progressive memory loss characterises Alzheimer's disease (AD), a neurodegenerative disorder. The pharmaceutical options available today are expensive, come with unwanted side effects, and are in short supply. Scientists and researchers have noticed that nutraceuticals have a big impact. The anti-Alzheimer's efficacy of nutraceuticals was examined in a number of clinical and preclinical investigations. The study of new therapeutic targets, such as the pathophysiological mechanisms and unique cascades, has resulted from the growing understanding of the AD pathogenesis. Therefore, the most effective and well-known nutraceuticals will be showcased in the present development, together with brief mechanisms involving antioxidants, autophagy control, anti-inflammatory, mitochondrial homeostasis, and more. Nutraceuticals have real-world impacts, and getting your hands on phytochemicals and other vital bioactive ingredients from therapeutically active foods is a top priority. Because of this, the term "functional foods" has been muddied and replaced with similar ones such as "pharmafoods," "medifoods," "vita foods," or "medicinal foods." Nutraceuticals are in high demand to counteract neurological interventions, and there is an urgent need to stick to healthy options. Nutraceuticals may play a preventative role in neurological therapies due to the demonstrated correlation between dietary patterns and lifestyle factors and neurodegeneration. Examining high-quality clinical trials is the focus of the present study, which touches on several important neurological topics. In light of nutraceuticals' promise as multi-targeted therapy for Alzheimer's disease, it is critical to assess them as promising lead molecules for the development of new drugs. Prospective studies should, according to the authors' understanding, take into account blood-brain barrier permeability alteration, bioavailability, and features of randomised clinical trials.